best glp-1 agonist companies Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Drugs

The additional GIP receptor activation contributes to its overall efficacy profile

Within this framework, absorption can be considered a metabolic control module: even when dietary composition appears adequate, altered gastrointestinal kinetics may reduce effective delivery of critical substrates, shifting metabolic constraint from nutrient intake to handling efficiency

North American region is leading the GLP-1 agonists market.

Drugs that mimic the bodys natural GLP-1 hormone have been around since 2005, but tirzepatide was the first to target both GLP-1 and the GIP receptors, which act in synergy with GLP-1 and help stimulate insulin release